Arbor Pharmaceuticals, Inc.

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Role: collaborator

Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry

Role: lead

An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension

Role: lead

Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate

Role: lead

Abuse Potential of HORIZANT With and Without Oxycodone in Healthy, Nondependent Recreational Opioid Users

Role: lead

An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users

Role: lead

Phase I Rising-dose Study to Assess Tolerability, Safety, Pharmacokinetics, Pharmacodynamics of AR09

Role: lead

Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting

Role: lead

HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder

Role: collaborator

Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)

Role: lead

Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets

Role: lead

Relative Bioavailability of AR10 Compared to Reference Product

Role: lead

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

Role: lead

AR08 for Treatment of ADHD in Children

Role: lead

A Comparison of Various Combinations of BiDil Capsules and BiDil Tablets in Healthy Human Volunteers

Role: lead

Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media

Role: lead

Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media

Role: lead